| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 90 | 2023 | 150 | 11.600 |
Why?
|
| DNA, Mitochondrial | 47 | 2023 | 65 | 6.300 |
Why?
|
| Brain | 31 | 2020 | 153 | 5.000 |
Why?
|
| Epilepsy | 23 | 2022 | 53 | 4.470 |
Why?
|
| Humans | 163 | 2023 | 4119 | 3.760 |
Why?
|
| Mutation | 37 | 2022 | 608 | 3.710 |
Why?
|
| Mitochondria, Muscle | 37 | 2013 | 37 | 3.630 |
Why?
|
| Oxidative Phosphorylation | 48 | 2021 | 52 | 3.510 |
Why?
|
| Muscle, Skeletal | 44 | 2019 | 73 | 3.420 |
Why?
|
| Animals | 157 | 2023 | 1545 | 3.380 |
Why?
|
| Potassium Channels | 11 | 2020 | 12 | 2.670 |
Why?
|
| Male | 110 | 2021 | 1811 | 2.560 |
Why?
|
| Reactive Oxygen Species | 17 | 2021 | 40 | 2.380 |
Why?
|
| Calcium | 21 | 2020 | 42 | 2.250 |
Why?
|
| Female | 100 | 2021 | 2147 | 2.120 |
Why?
|
| Rats | 83 | 2020 | 164 | 2.050 |
Why?
|
| Hippocampus | 19 | 2017 | 48 | 2.020 |
Why?
|
| Epilepsy, Temporal Lobe | 11 | 2017 | 21 | 1.910 |
Why?
|
| Neurons | 13 | 2016 | 78 | 1.850 |
Why?
|
| Electron Transport Complex IV | 22 | 2021 | 26 | 1.810 |
Why?
|
| Adult | 57 | 2021 | 944 | 1.750 |
Why?
|
| Mitochondrial Diseases | 14 | 2021 | 16 | 1.590 |
Why?
|
| Oxygen Consumption | 43 | 2012 | 45 | 1.560 |
Why?
|
| Mitochondria, Liver | 38 | 2017 | 39 | 1.430 |
Why?
|
| Muscle Fibers, Skeletal | 19 | 2019 | 24 | 1.420 |
Why?
|
| Epilepsy, Generalized | 10 | 2022 | 21 | 1.400 |
Why?
|
| Amyotrophic Lateral Sclerosis | 10 | 2021 | 15 | 1.310 |
Why?
|
| Anticonvulsants | 13 | 2022 | 15 | 1.270 |
Why?
|
| Middle Aged | 43 | 2021 | 843 | 1.230 |
Why?
|
| Energy Metabolism | 15 | 2015 | 47 | 1.220 |
Why?
|
| Oxidation-Reduction | 40 | 2020 | 58 | 1.150 |
Why?
|
| Intellectual Disability | 3 | 2023 | 122 | 1.140 |
Why?
|
| Seizures | 5 | 2022 | 24 | 1.130 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 14 | 2019 | 14 | 1.130 |
Why?
|
| Superoxides | 6 | 2010 | 8 | 1.130 |
Why?
|
| Phenotype | 13 | 2023 | 479 | 1.120 |
Why?
|
| Schistosoma mansoni | 16 | 2003 | 17 | 1.080 |
Why?
|
| Mitochondrial Proteins | 8 | 2018 | 35 | 1.070 |
Why?
|
| NAD | 22 | 2008 | 23 | 1.050 |
Why?
|
| Electron Transport Complex I | 14 | 2021 | 18 | 1.020 |
Why?
|
| Transcription Factors | 4 | 2023 | 256 | 1.000 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 3 | 2018 | 3 | 0.980 |
Why?
|
| NADP | 17 | 2002 | 17 | 0.930 |
Why?
|
| Neurodegenerative Diseases | 4 | 2013 | 15 | 0.920 |
Why?
|
| DNA Replication | 7 | 2023 | 11 | 0.920 |
Why?
|
| Zalcitabine | 1 | 2023 | 1 | 0.900 |
Why?
|
| Valproic Acid | 7 | 2020 | 9 | 0.890 |
Why?
|
| Nerve Tissue Proteins | 5 | 2022 | 74 | 0.890 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2023 | 529 | 0.870 |
Why?
|
| Electron Transport | 20 | 2021 | 22 | 0.860 |
Why?
|
| Mice | 29 | 2022 | 737 | 0.860 |
Why?
|
| Adenosine Triphosphate | 32 | 2020 | 56 | 0.830 |
Why?
|
| Flavoproteins | 10 | 1998 | 10 | 0.830 |
Why?
|
| Aged | 24 | 2021 | 580 | 0.810 |
Why?
|
| Liver | 10 | 2017 | 61 | 0.760 |
Why?
|
| Genome-Wide Association Study | 8 | 2023 | 417 | 0.760 |
Why?
|
| Ion Channel Gating | 6 | 2010 | 8 | 0.760 |
Why?
|
| Membrane Potential, Mitochondrial | 6 | 2020 | 9 | 0.760 |
Why?
|
| Rats, Wistar | 17 | 2018 | 28 | 0.750 |
Why?
|
| Hydrogen Peroxide | 8 | 2014 | 22 | 0.750 |
Why?
|
| Adolescent | 27 | 2021 | 493 | 0.740 |
Why?
|
| Oxidative Stress | 10 | 2017 | 50 | 0.660 |
Why?
|
| Alleles | 4 | 2023 | 221 | 0.660 |
Why?
|
| Membrane Proteins | 2 | 2016 | 101 | 0.650 |
Why?
|
| Child | 20 | 2021 | 557 | 0.650 |
Why?
|
| Fibroblasts | 10 | 2021 | 71 | 0.640 |
Why?
|
| Amides | 1 | 2017 | 1 | 0.630 |
Why?
|
| Mitochondrial Myopathies | 11 | 2003 | 11 | 0.620 |
Why?
|
| Nervous System Diseases | 2 | 2016 | 13 | 0.610 |
Why?
|
| Saponins | 12 | 2002 | 12 | 0.610 |
Why?
|
| Mitochondria, Heart | 12 | 2014 | 14 | 0.600 |
Why?
|
| Aspartic Acid | 5 | 2020 | 6 | 0.590 |
Why?
|
| MERRF Syndrome | 3 | 2014 | 4 | 0.590 |
Why?
|
| In Vitro Techniques | 25 | 2010 | 53 | 0.590 |
Why?
|
| DNA Mutational Analysis | 12 | 2015 | 122 | 0.580 |
Why?
|
| Aging | 3 | 2022 | 92 | 0.580 |
Why?
|
| Pyruvic Acid | 7 | 2020 | 8 | 0.570 |
Why?
|
| NADH Dehydrogenase | 3 | 2014 | 5 | 0.570 |
Why?
|
| Young Adult | 14 | 2021 | 345 | 0.570 |
Why?
|
| Genetic Variation | 5 | 2021 | 189 | 0.560 |
Why?
|
| Adenosine Diphosphate | 27 | 2008 | 27 | 0.560 |
Why?
|
| Parkinson Disease | 6 | 2012 | 26 | 0.560 |
Why?
|
| Submitochondrial Particles | 5 | 2008 | 5 | 0.560 |
Why?
|
| Superoxide Dismutase | 6 | 2007 | 13 | 0.550 |
Why?
|
| Cells, Cultured | 13 | 2023 | 261 | 0.550 |
Why?
|
| Membrane Potentials | 17 | 2020 | 21 | 0.550 |
Why?
|
| Pedigree | 10 | 2021 | 304 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 103 | 0.530 |
Why?
|
| Epilepsies, Partial | 3 | 2022 | 11 | 0.530 |
Why?
|
| Parathyroid Diseases | 1 | 2014 | 1 | 0.510 |
Why?
|
| Parathyroid Glands | 1 | 2014 | 1 | 0.510 |
Why?
|
| Oxyphil Cells | 1 | 2014 | 1 | 0.510 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2014 | 4 | 0.510 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2014 | 7 | 0.510 |
Why?
|
| Myoblasts | 2 | 2011 | 3 | 0.510 |
Why?
|
| Kinetics | 25 | 2008 | 43 | 0.510 |
Why?
|
| Cell Membrane Permeability | 10 | 2008 | 10 | 0.500 |
Why?
|
| Hemin | 1 | 2014 | 2 | 0.500 |
Why?
|
| Electron Transport Complex III | 6 | 2010 | 6 | 0.490 |
Why?
|
| Sequence Deletion | 6 | 2015 | 51 | 0.490 |
Why?
|
| Desmin | 5 | 2020 | 6 | 0.480 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 8 | 0.480 |
Why?
|
| Base Sequence | 20 | 2021 | 275 | 0.480 |
Why?
|
| DNA-Directed DNA Polymerase | 6 | 2014 | 9 | 0.480 |
Why?
|
| Exons | 4 | 2016 | 97 | 0.470 |
Why?
|
| Intracellular Membranes | 9 | 2008 | 10 | 0.470 |
Why?
|
| Oxygen | 9 | 2015 | 24 | 0.470 |
Why?
|
| Free Radical Scavengers | 2 | 2021 | 3 | 0.460 |
Why?
|
| Mammals | 3 | 2023 | 12 | 0.460 |
Why?
|
| Presynaptic Terminals | 1 | 2013 | 2 | 0.450 |
Why?
|
| Creatine | 2 | 2003 | 2 | 0.450 |
Why?
|
| Benzimidazoles | 8 | 2014 | 10 | 0.440 |
Why?
|
| Skin | 6 | 2021 | 42 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 9 | 2020 | 226 | 0.440 |
Why?
|
| Adenine Nucleotides | 13 | 1992 | 13 | 0.430 |
Why?
|
| NADH, NADPH Oxidoreductases | 12 | 2002 | 13 | 0.430 |
Why?
|
| Mutation, Missense | 6 | 2021 | 124 | 0.420 |
Why?
|
| Gene Deletion | 7 | 2015 | 57 | 0.420 |
Why?
|
| Cell Differentiation | 3 | 2012 | 199 | 0.410 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 122 | 0.410 |
Why?
|
| Amino Acid Sequence | 15 | 2021 | 186 | 0.410 |
Why?
|
| Status Epilepticus | 3 | 2006 | 3 | 0.410 |
Why?
|
| Neuroprotective Agents | 5 | 2013 | 6 | 0.400 |
Why?
|
| Fructose | 4 | 2017 | 6 | 0.400 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 7 | 2017 | 7 | 0.400 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 210 | 0.390 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 143 | 0.390 |
Why?
|
| Signal Transduction | 5 | 2020 | 261 | 0.390 |
Why?
|
| Thrombocytopenia | 2 | 2001 | 9 | 0.390 |
Why?
|
| Microscopy, Fluorescence | 7 | 2002 | 25 | 0.390 |
Why?
|
| Sclerosis | 6 | 2017 | 9 | 0.390 |
Why?
|
| Potassium Channel Blockers | 5 | 2014 | 5 | 0.390 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2014 | 43 | 0.380 |
Why?
|
| Molecular Sequence Data | 18 | 2013 | 301 | 0.360 |
Why?
|
| Child, Preschool | 9 | 2021 | 378 | 0.360 |
Why?
|
| Indoles | 4 | 2018 | 9 | 0.360 |
Why?
|
| HEK293 Cells | 4 | 2023 | 64 | 0.360 |
Why?
|
| Case-Control Studies | 10 | 2022 | 322 | 0.360 |
Why?
|
| Spectrometry, Fluorescence | 8 | 1999 | 10 | 0.350 |
Why?
|
| Genome, Mitochondrial | 3 | 2023 | 5 | 0.350 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 4 | 2019 | 6 | 0.350 |
Why?
|
| Cell Death | 4 | 2013 | 20 | 0.340 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 4 | 2020 | 4 | 0.340 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 8 | 0.340 |
Why?
|
| Drug Resistance | 3 | 2020 | 6 | 0.330 |
Why?
|
| Carrier Proteins | 4 | 2014 | 65 | 0.320 |
Why?
|
| Exodeoxyribonucleases | 4 | 2019 | 8 | 0.320 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 7 | 0.320 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2023 | 32 | 0.320 |
Why?
|
| Flow Cytometry | 4 | 2001 | 71 | 0.310 |
Why?
|
| GTP Phosphohydrolases | 3 | 2019 | 11 | 0.310 |
Why?
|
| Spermatozoa | 4 | 1991 | 10 | 0.310 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 9 | 2003 | 9 | 0.310 |
Why?
|
| Cell Respiration | 10 | 2015 | 16 | 0.310 |
Why?
|
| Cytosol | 6 | 2020 | 12 | 0.300 |
Why?
|
| Polymorphism, Genetic | 6 | 2008 | 68 | 0.300 |
Why?
|
| Pyramidal Cells | 3 | 2007 | 4 | 0.300 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2021 | 2 | 0.300 |
Why?
|
| Kidney Cortex | 4 | 1993 | 4 | 0.300 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 3 | 2016 | 5 | 0.290 |
Why?
|
| Blotting, Southern | 10 | 2004 | 15 | 0.290 |
Why?
|
| Heterozygote | 6 | 2020 | 94 | 0.290 |
Why?
|
| Polymerase Chain Reaction | 8 | 2019 | 97 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 552 | 0.280 |
Why?
|
| DNA Damage | 2 | 2006 | 77 | 0.270 |
Why?
|
| Mitochondrial Membranes | 2 | 2020 | 2 | 0.270 |
Why?
|
| Pilocarpine | 5 | 2006 | 6 | 0.260 |
Why?
|
| Genetic Testing | 2 | 2022 | 66 | 0.260 |
Why?
|
| DNA Polymerase gamma | 7 | 2018 | 7 | 0.260 |
Why?
|
| Coloring Agents | 2 | 2002 | 5 | 0.260 |
Why?
|
| Cytochrome b Group | 5 | 2001 | 5 | 0.250 |
Why?
|
| Point Mutation | 6 | 2008 | 36 | 0.250 |
Why?
|
| Copper | 2 | 2006 | 3 | 0.250 |
Why?
|
| Blood Glucose | 2 | 2012 | 59 | 0.250 |
Why?
|
| Muscular Diseases | 4 | 2016 | 17 | 0.250 |
Why?
|
| Infant | 6 | 2018 | 267 | 0.240 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 45 | 0.240 |
Why?
|
| Potassium Channels, Voltage-Gated | 4 | 2020 | 7 | 0.240 |
Why?
|
| Ubiquinone | 4 | 2010 | 4 | 0.240 |
Why?
|
| Calcium Channels | 2 | 2020 | 9 | 0.240 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2021 | 3 | 0.240 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 73 | 0.230 |
Why?
|
| Blepharoptosis | 4 | 2008 | 5 | 0.230 |
Why?
|
| Homozygote | 4 | 2021 | 117 | 0.230 |
Why?
|
| DNA | 6 | 2013 | 102 | 0.230 |
Why?
|
| Organ Specificity | 2 | 2003 | 37 | 0.230 |
Why?
|
| Motor Cortex | 2 | 2006 | 3 | 0.230 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 2 | 0.230 |
Why?
|
| Intermediate Filaments | 2 | 2016 | 3 | 0.230 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2023 | 4 | 0.230 |
Why?
|
| Pharmacogenomic Variants | 2 | 2020 | 3 | 0.230 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 161 | 0.230 |
Why?
|
| Models, Biological | 5 | 2012 | 115 | 0.230 |
Why?
|
| DNA, Helminth | 5 | 2001 | 9 | 0.220 |
Why?
|
| Antigens, CD | 2 | 2013 | 48 | 0.220 |
Why?
|
| Immunity | 1 | 2023 | 18 | 0.220 |
Why?
|
| Pyridines | 2 | 2001 | 6 | 0.220 |
Why?
|
| Class II Phosphatidylinositol 3-Kinases | 1 | 2022 | 1 | 0.220 |
Why?
|
| Myoclonic Epilepsies, Progressive | 2 | 2013 | 2 | 0.220 |
Why?
|
| Muscles | 3 | 2008 | 11 | 0.220 |
Why?
|
| Age of Onset | 4 | 2016 | 40 | 0.220 |
Why?
|
| Potassium Cyanide | 2 | 2000 | 3 | 0.220 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 3 | 0.210 |
Why?
|
| Protein Subunits | 3 | 2021 | 15 | 0.210 |
Why?
|
| Mental Disorders | 2 | 2018 | 12 | 0.210 |
Why?
|
| RNA, Transfer | 3 | 2013 | 8 | 0.210 |
Why?
|
| Brain Chemistry | 3 | 1999 | 5 | 0.210 |
Why?
|
| Uncoupling Agents | 6 | 2010 | 6 | 0.210 |
Why?
|
| Cell Line | 6 | 2021 | 137 | 0.210 |
Why?
|
| Potassium Channels, Calcium-Activated | 3 | 2020 | 3 | 0.210 |
Why?
|
| Heme | 2 | 2020 | 3 | 0.210 |
Why?
|
| Fluorescein Angiography | 1 | 2021 | 1 | 0.200 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2021 | 1 | 0.200 |
Why?
|
| Visual Acuity | 1 | 2021 | 2 | 0.200 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 9 | 0.200 |
Why?
|
| Microcephaly | 1 | 2022 | 65 | 0.200 |
Why?
|
| Hexokinase | 11 | 2003 | 12 | 0.200 |
Why?
|
| Fluorescence | 5 | 1998 | 12 | 0.200 |
Why?
|
| Models, Molecular | 3 | 2021 | 50 | 0.200 |
Why?
|
| Myocardium | 7 | 2020 | 28 | 0.200 |
Why?
|
| Myoclonic Epilepsy, Juvenile | 2 | 2019 | 3 | 0.200 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 1 | 0.200 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2021 | 5 | 0.200 |
Why?
|
| Diazoxide | 1 | 2001 | 1 | 0.200 |
Why?
|
| Benzoates | 1 | 2001 | 3 | 0.200 |
Why?
|
| Blood Platelets | 1 | 2001 | 10 | 0.200 |
Why?
|
| Gaucher Disease | 1 | 2001 | 2 | 0.200 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2021 | 2 | 0.200 |
Why?
|
| Rotenone | 10 | 2000 | 11 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2021 | 191 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 13 | 0.200 |
Why?
|
| MELAS Syndrome | 3 | 2012 | 3 | 0.200 |
Why?
|
| Cattle | 13 | 2000 | 22 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 37 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2007 | 15 | 0.190 |
Why?
|
| Retrospective Studies | 5 | 2021 | 120 | 0.190 |
Why?
|
| Glutathione | 5 | 2017 | 8 | 0.190 |
Why?
|
| Caffeine | 4 | 1994 | 8 | 0.190 |
Why?
|
| Genes, Recessive | 2 | 2021 | 44 | 0.190 |
Why?
|
| Ion Channels | 2 | 2014 | 7 | 0.190 |
Why?
|
| Boranes | 1 | 2020 | 1 | 0.190 |
Why?
|
| Carbon Monoxide | 1 | 2020 | 1 | 0.190 |
Why?
|
| Carbonates | 1 | 2020 | 1 | 0.190 |
Why?
|
| N-substituted Glycines | 1 | 2020 | 1 | 0.190 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 2 | 0.190 |
Why?
|
| Proteins | 3 | 2009 | 77 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 50 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 2 | 1997 | 4 | 0.190 |
Why?
|
| Atrioventricular Block | 1 | 2020 | 1 | 0.190 |
Why?
|
| Malates | 6 | 2020 | 6 | 0.190 |
Why?
|
| Cloning, Molecular | 9 | 2013 | 64 | 0.180 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 1 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 4 | 0.180 |
Why?
|
| Proton-Translocating ATPases | 6 | 2010 | 8 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 206 | 0.180 |
Why?
|
| Gene Rearrangement | 3 | 2015 | 21 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 99 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 36 | 0.180 |
Why?
|
| Paternal Inheritance | 1 | 2019 | 4 | 0.180 |
Why?
|
| RNA, Transfer, Leu | 2 | 2012 | 4 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2001 | 3 | 0.180 |
Why?
|
| Alkaline Phosphatase | 3 | 1994 | 6 | 0.180 |
Why?
|
| Homeostasis | 3 | 2011 | 50 | 0.180 |
Why?
|
| Kainic Acid | 1 | 1999 | 1 | 0.180 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1999 | 2 | 0.180 |
Why?
|
| Organ Culture Techniques | 4 | 2014 | 6 | 0.180 |
Why?
|
| Phosphates | 7 | 1993 | 12 | 0.180 |
Why?
|
| Brain Diseases | 2 | 2018 | 15 | 0.180 |
Why?
|
| Behavior, Animal | 3 | 2009 | 13 | 0.170 |
Why?
|
| Oculomotor Muscles | 1 | 2019 | 1 | 0.170 |
Why?
|
| RNA, Transfer, Asn | 1 | 2019 | 1 | 0.170 |
Why?
|
| Quadriceps Muscle | 1 | 2019 | 1 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 111 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2019 | 2 | 0.170 |
Why?
|
| Disease Progression | 4 | 2013 | 72 | 0.170 |
Why?
|
| Permeability | 4 | 2009 | 5 | 0.170 |
Why?
|
| CpG Islands | 1 | 2019 | 51 | 0.170 |
Why?
|
| Siblings | 2 | 2016 | 28 | 0.170 |
Why?
|
| Fatty Acids | 3 | 2014 | 25 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2022 | 174 | 0.170 |
Why?
|
| Succinate Dehydrogenase | 7 | 2012 | 8 | 0.170 |
Why?
|
| Receptors, GABA-A | 1 | 2018 | 8 | 0.170 |
Why?
|
| DNA Cleavage | 1 | 2018 | 1 | 0.160 |
Why?
|
| DNA, Ribosomal | 2 | 1990 | 13 | 0.160 |
Why?
|
| Maze Learning | 3 | 2009 | 5 | 0.160 |
Why?
|
| Membrane Transport Modulators | 1 | 2018 | 1 | 0.160 |
Why?
|
| Gene Editing | 1 | 2018 | 16 | 0.160 |
Why?
|
| Drug Eruptions | 1 | 2017 | 1 | 0.160 |
Why?
|
| Phenytoin | 1 | 2017 | 2 | 0.160 |
Why?
|
| Apolipoproteins | 1 | 2017 | 3 | 0.160 |
Why?
|
| Lipid Bilayers | 3 | 2009 | 4 | 0.160 |
Why?
|
| Cytochrome c Group | 5 | 2003 | 5 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 1997 | 1 | 0.160 |
Why?
|
| Blotting, Western | 8 | 2012 | 38 | 0.160 |
Why?
|
| Cell Survival | 2 | 2010 | 45 | 0.160 |
Why?
|
| Cognition Disorders | 2 | 2022 | 9 | 0.160 |
Why?
|
| Models, Neurological | 2 | 2010 | 2 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2019 | 186 | 0.150 |
Why?
|
| Median Nerve | 2 | 2017 | 2 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2017 | 10 | 0.150 |
Why?
|
| Multienzyme Complexes | 4 | 2003 | 6 | 0.150 |
Why?
|
| Axons | 1 | 2017 | 12 | 0.150 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2017 | 2 | 0.150 |
Why?
|
| Glutamic Acid | 4 | 2020 | 11 | 0.150 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 6 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2020 | 149 | 0.150 |
Why?
|
| Adenylate Kinase | 3 | 1994 | 4 | 0.150 |
Why?
|
| Creatine Kinase | 5 | 2001 | 7 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 1996 | 25 | 0.150 |
Why?
|
| Microglia | 2 | 2013 | 35 | 0.140 |
Why?
|
| Peptides | 2 | 2014 | 38 | 0.140 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2013 | 6 | 0.140 |
Why?
|
| Leigh Disease | 1 | 2015 | 4 | 0.140 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 111 | 0.140 |
Why?
|
| Quinone Reductases | 3 | 1985 | 3 | 0.140 |
Why?
|
| DNA, Complementary | 7 | 2003 | 44 | 0.140 |
Why?
|
| Exome | 1 | 2016 | 124 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2010 | 9 | 0.140 |
Why?
|
| Helminth Proteins | 4 | 2003 | 4 | 0.140 |
Why?
|
| Choline | 3 | 2005 | 4 | 0.130 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Diet, Ketogenic | 1 | 2015 | 1 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 3 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 3 | 2013 | 249 | 0.130 |
Why?
|
| Glutamates | 3 | 1995 | 3 | 0.130 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 16 | 0.130 |
Why?
|
| Europe | 3 | 2020 | 60 | 0.130 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 3 | 2010 | 3 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2015 | 25 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 19 | 0.130 |
Why?
|
| Piracetam | 2 | 2012 | 3 | 0.130 |
Why?
|
| Metaplasia | 1 | 2014 | 1 | 0.130 |
Why?
|
| Atractyloside | 10 | 1993 | 10 | 0.130 |
Why?
|
| Glutamine | 2 | 2007 | 4 | 0.130 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 26 | 0.130 |
Why?
|
| Risk Factors | 4 | 2018 | 265 | 0.130 |
Why?
|
| RNA, Ribosomal | 3 | 1985 | 7 | 0.130 |
Why?
|
| Cell Compartmentation | 4 | 1994 | 6 | 0.130 |
Why?
|
| Time Factors | 5 | 2009 | 115 | 0.130 |
Why?
|
| Electroencephalography | 4 | 2021 | 13 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 2 | 0.130 |
Why?
|
| Cellular Senescence | 1 | 2014 | 26 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 173 | 0.120 |
Why?
|
| Inflammation | 1 | 2016 | 179 | 0.120 |
Why?
|
| Astrocytoma | 1 | 2014 | 2 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 5 | 0.120 |
Why?
|
| Placenta | 1 | 1994 | 5 | 0.120 |
Why?
|
| DNA, Recombinant | 2 | 2006 | 5 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2014 | 55 | 0.120 |
Why?
|
| Biopsy | 6 | 2004 | 31 | 0.120 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 3 | 0.120 |
Why?
|
| Chloride Channels | 2 | 2007 | 4 | 0.120 |
Why?
|
| Synapses | 1 | 2014 | 10 | 0.120 |
Why?
|
| Apoptosis | 4 | 2018 | 94 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 1994 | 11 | 0.120 |
Why?
|
| Microscopy, Electron | 7 | 2012 | 18 | 0.120 |
Why?
|
| Models, Chemical | 3 | 2002 | 12 | 0.120 |
Why?
|
| Respiratory Burst | 1 | 2013 | 1 | 0.120 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2013 | 9 | 0.120 |
Why?
|
| Seizures, Febrile | 1 | 2013 | 2 | 0.120 |
Why?
|
| Lipid Peroxidation | 3 | 2006 | 8 | 0.120 |
Why?
|
| Glyburide | 2 | 2005 | 2 | 0.120 |
Why?
|
| Motor Neuron Disease | 2 | 2006 | 2 | 0.120 |
Why?
|
| Cytochromes | 4 | 1994 | 4 | 0.120 |
Why?
|
| Muscarinic Agonists | 2 | 2003 | 2 | 0.110 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 5 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2013 | 5 | 0.110 |
Why?
|
| Nucleic Acids | 1 | 1992 | 3 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 78 | 0.110 |
Why?
|
| Enzyme Activation | 5 | 2009 | 17 | 0.110 |
Why?
|
| Adipocytes, Brown | 1 | 2012 | 1 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cyclic GMP | 1 | 2012 | 3 | 0.110 |
Why?
|
| Guanylate Cyclase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 5 | 0.110 |
Why?
|
| Aggression | 1 | 2012 | 1 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2012 | 1 | 0.110 |
Why?
|
| Dopamine | 1 | 2012 | 6 | 0.110 |
Why?
|
| Insulin | 2 | 2012 | 61 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 93 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 17 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2012 | 26 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 20 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2020 | 115 | 0.110 |
Why?
|
| Gene Dosage | 3 | 2019 | 17 | 0.110 |
Why?
|
| Nucleotides | 3 | 2022 | 8 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 1992 | 90 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2012 | 1 | 0.110 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2012 | 1 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 7 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 2012 | 1 | 0.110 |
Why?
|
| Mental Processes | 1 | 2012 | 1 | 0.110 |
Why?
|
| Fear | 1 | 2012 | 3 | 0.110 |
Why?
|
| Amygdala | 1 | 2012 | 3 | 0.110 |
Why?
|
| Social Behavior | 1 | 2012 | 5 | 0.110 |
Why?
|
| Kearns-Sayre Syndrome | 3 | 2008 | 4 | 0.110 |
Why?
|
| Genes | 3 | 1987 | 22 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2014 | 263 | 0.110 |
Why?
|
| Genotype | 4 | 2020 | 320 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2012 | 16 | 0.110 |
Why?
|
| Potassium Chloride | 4 | 2001 | 5 | 0.100 |
Why?
|
| Receptors, Scavenger | 1 | 2011 | 1 | 0.100 |
Why?
|
| Lysosome-Associated Membrane Glycoproteins | 1 | 2011 | 4 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diplopia | 2 | 2017 | 2 | 0.100 |
Why?
|
| Blotting, Northern | 6 | 2001 | 22 | 0.100 |
Why?
|
| DNA Copy Number Variations | 3 | 2020 | 79 | 0.100 |
Why?
|
| Succinic Acid | 4 | 1999 | 5 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 2 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2012 | 64 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2000 | 22 | 0.100 |
Why?
|
| Obesity | 1 | 2012 | 86 | 0.100 |
Why?
|
| Protein Binding | 3 | 2020 | 97 | 0.100 |
Why?
|
| Platelet Count | 2 | 2001 | 3 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 4 | 2008 | 17 | 0.100 |
Why?
|
| Blindness | 1 | 2010 | 2 | 0.100 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 10 | 0.100 |
Why?
|
| Enzymes | 1 | 1990 | 3 | 0.100 |
Why?
|
| Diazonium Compounds | 1 | 1990 | 1 | 0.100 |
Why?
|
| Naphthols | 1 | 1990 | 1 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 1990 | 3 | 0.100 |
Why?
|
| Fluorometry | 4 | 1997 | 5 | 0.100 |
Why?
|
| Potassium | 3 | 2009 | 5 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2003 | 21 | 0.100 |
Why?
|
| Pan paniscus | 1 | 2010 | 1 | 0.100 |
Why?
|
| Benzopyrans | 1 | 2010 | 1 | 0.100 |
Why?
|
| Cytoprotection | 1 | 2010 | 3 | 0.100 |
Why?
|
| Protein Kinases | 2 | 2009 | 11 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 1990 | 26 | 0.100 |
Why?
|
| Imidazoles | 1 | 2010 | 12 | 0.100 |
Why?
|
| DNA Repair | 2 | 2012 | 60 | 0.100 |
Why?
|
| Mathematics | 6 | 1991 | 8 | 0.090 |
Why?
|
| Citrate (si)-Synthase | 4 | 2012 | 4 | 0.090 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 8 | 0.090 |
Why?
|
| Cytoskeleton | 2 | 2016 | 12 | 0.090 |
Why?
|
| RNA, Transfer, Phe | 1 | 2010 | 1 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2001 | 83 | 0.090 |
Why?
|
| Animals, Newborn | 4 | 2009 | 17 | 0.090 |
Why?
|
| Longevity | 1 | 2010 | 40 | 0.090 |
Why?
|
| Glioma | 1 | 2009 | 12 | 0.090 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2009 | 2 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2012 | 25 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 16 | 0.090 |
Why?
|
| Genome, Human | 2 | 2023 | 104 | 0.090 |
Why?
|
| Calpain | 3 | 2018 | 9 | 0.090 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 13 | 0.090 |
Why?
|
| Pyruvates | 5 | 1991 | 5 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2009 | 2 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 7 | 0.090 |
Why?
|
| Memory | 2 | 2006 | 3 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2012 | 20 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2019 | 15 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2008 | 7 | 0.080 |
Why?
|
| Apraxias | 1 | 2008 | 2 | 0.080 |
Why?
|
| Chromosome Deletion | 2 | 2008 | 45 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2008 | 4 | 0.080 |
Why?
|
| Leukotriene C4 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Charybdotoxin | 1 | 2008 | 1 | 0.080 |
Why?
|
| Plectin | 1 | 2008 | 1 | 0.080 |
Why?
|
| Esters | 1 | 2008 | 2 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2008 | 3 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2010 | 8 | 0.080 |
Why?
|
| Cyclosporine | 2 | 2005 | 4 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Nucleotidyltransferases | 2 | 1990 | 8 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 18 | 0.080 |
Why?
|
| Mitochondrial Swelling | 4 | 2005 | 4 | 0.080 |
Why?
|
| Carbamazepine | 2 | 2017 | 2 | 0.080 |
Why?
|
| Cell Count | 2 | 2007 | 18 | 0.080 |
Why?
|
| Diazepam | 2 | 2006 | 2 | 0.080 |
Why?
|
| Invertebrate Hormones | 1 | 1987 | 1 | 0.080 |
Why?
|
| Lactates | 4 | 2007 | 4 | 0.080 |
Why?
|
| Succinates | 7 | 2007 | 7 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 45 | 0.080 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 2007 | 1 | 0.080 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2007 | 1 | 0.080 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2006 | 1 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2006 | 20 | 0.070 |
Why?
|
| Carnitine | 2 | 2004 | 3 | 0.070 |
Why?
|
| Antimycin A | 5 | 1990 | 6 | 0.070 |
Why?
|
| Hyperhomocysteinemia | 1 | 2006 | 1 | 0.070 |
Why?
|
| Histones | 1 | 2006 | 36 | 0.070 |
Why?
|
| Epilepsy, Absence | 2 | 2019 | 5 | 0.070 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2019 | 4 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2009 | 20 | 0.070 |
Why?
|
| Muscular Atrophy | 1 | 2005 | 2 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1997 | 11 | 0.070 |
Why?
|
| Diffusion | 2 | 2001 | 2 | 0.070 |
Why?
|
| Horseradish Peroxidase | 1 | 2005 | 1 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 139 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2003 | 8 | 0.070 |
Why?
|
| Triazines | 2 | 2017 | 3 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 11 | 0.070 |
Why?
|
| Forearm | 2 | 2017 | 2 | 0.070 |
Why?
|
| Electrophysiological Phenomena | 2 | 2017 | 2 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 16 | 0.070 |
Why?
|
| Atrophy | 2 | 2017 | 7 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 6 | 0.070 |
Why?
|
| Grasshoppers | 1 | 1985 | 1 | 0.070 |
Why?
|
| RNA | 2 | 2004 | 54 | 0.070 |
Why?
|
| Ischemia | 1 | 1985 | 1 | 0.070 |
Why?
|
| DNA Primers | 2 | 2013 | 41 | 0.060 |
Why?
|
| Kindling, Neurologic | 1 | 2004 | 1 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 3 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 12 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 26 | 0.060 |
Why?
|
| Microscopy, Video | 2 | 2002 | 4 | 0.060 |
Why?
|
| Family Health | 2 | 2018 | 24 | 0.060 |
Why?
|
| DNA, Single-Stranded | 2 | 2023 | 4 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 33 | 0.060 |
Why?
|
| Ruthenium | 1 | 1984 | 1 | 0.060 |
Why?
|
| Ruthenium Compounds | 1 | 1984 | 1 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2021 | 30 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 1984 | 12 | 0.060 |
Why?
|
| Ferricyanides | 1 | 1984 | 1 | 0.060 |
Why?
|
| Antioxidants | 1 | 2004 | 7 | 0.060 |
Why?
|
| RNA Splicing Factors | 2 | 2015 | 8 | 0.060 |
Why?
|
| Chelating Agents | 2 | 2006 | 3 | 0.060 |
Why?
|
| Gene Expression | 3 | 2012 | 138 | 0.060 |
Why?
|
| Myosins | 2 | 1994 | 8 | 0.060 |
Why?
|
| Egg Proteins | 1 | 2003 | 3 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 22 | 0.060 |
Why?
|
| Food, Formulated | 1 | 2003 | 1 | 0.060 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 1 | 0.060 |
Why?
|
| Valinomycin | 3 | 2001 | 3 | 0.060 |
Why?
|
| Chickens | 2 | 2001 | 6 | 0.060 |
Why?
|
| Xenopus laevis | 2 | 2001 | 10 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2003 | 10 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 5 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 7 | 0.060 |
Why?
|
| Sperm Motility | 3 | 1991 | 4 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2017 | 8 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 4 | 2006 | 7 | 0.060 |
Why?
|
| Oxaloacetates | 4 | 1982 | 4 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2023 | 9 | 0.060 |
Why?
|
| Pyruvate Kinase | 1 | 1983 | 2 | 0.060 |
Why?
|
| Myofibrils | 1 | 2003 | 2 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2003 | 2 | 0.060 |
Why?
|
| HLA-DRB1 Chains | 1 | 2023 | 11 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 15 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 2 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2023 | 21 | 0.060 |
Why?
|
| Oligomycins | 6 | 1997 | 6 | 0.060 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2003 | 2 | 0.060 |
Why?
|
| Temperature | 3 | 1996 | 29 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2003 | 120 | 0.060 |
Why?
|
| Proteome | 1 | 2023 | 57 | 0.060 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2002 | 1 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 2 | 0.060 |
Why?
|
| Haplotypes | 1 | 2023 | 122 | 0.060 |
Why?
|
| Genetic Counseling | 1 | 2022 | 9 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 18 | 0.050 |
Why?
|
| Digitonin | 3 | 2012 | 3 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2020 | 11 | 0.050 |
Why?
|
| Family | 2 | 2013 | 36 | 0.050 |
Why?
|
| Lasers | 2 | 1999 | 7 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 26 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2022 | 4 | 0.050 |
Why?
|
| Shaw Potassium Channels | 1 | 2022 | 1 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2002 | 20 | 0.050 |
Why?
|
| Ions | 3 | 2009 | 10 | 0.050 |
Why?
|
| Polarography | 5 | 2000 | 5 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2022 | 4 | 0.050 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 2006 | 2 | 0.050 |
Why?
|
| Cognition | 1 | 2022 | 29 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 55 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2002 | 62 | 0.050 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2001 | 2 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2003 | 33 | 0.050 |
Why?
|
| Reference Values | 1 | 2001 | 11 | 0.050 |
Why?
|
| Digoxigenin | 2 | 1992 | 2 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 1999 | 10 | 0.050 |
Why?
|
| Plasmids | 3 | 2001 | 27 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2002 | 31 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pregnancy | 2 | 2009 | 113 | 0.050 |
Why?
|
| Electroretinography | 1 | 2021 | 3 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 1997 | 133 | 0.050 |
Why?
|
| Acetoacetates | 3 | 1990 | 3 | 0.050 |
Why?
|
| Neoplasms | 1 | 2003 | 135 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2009 | 51 | 0.050 |
Why?
|
| Torpedo | 1 | 2001 | 1 | 0.050 |
Why?
|
| Platelet Transfusion | 1 | 2001 | 1 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2001 | 1 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2001 | 1 | 0.050 |
Why?
|
| Germany | 1 | 2021 | 251 | 0.050 |
Why?
|
| Decanoic Acids | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hydroxy Acids | 1 | 2001 | 1 | 0.050 |
Why?
|
| Penetrance | 1 | 2021 | 15 | 0.050 |
Why?
|
| Bleomycin | 1 | 2001 | 2 | 0.050 |
Why?
|
| Ifosfamide | 1 | 2001 | 2 | 0.050 |
Why?
|
| Vincristine | 1 | 2001 | 6 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Prednisone | 1 | 2001 | 8 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 25 | 0.050 |
Why?
|
| Radiography | 1 | 2001 | 11 | 0.050 |
Why?
|
| Etoposide | 1 | 2001 | 10 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 25 | 0.050 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1981 | 1 | 0.050 |
Why?
|
| Carbon Tetrachloride | 1 | 1981 | 2 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2001 | 13 | 0.050 |
Why?
|
| Unfolded Protein Response | 1 | 2021 | 6 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2000 | 6 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2018 | 21 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 54 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 1 | 0.050 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2020 | 1 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 68 | 0.050 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2000 | 1 | 0.050 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 2 | 1999 | 2 | 0.050 |
Why?
|
| Dopamine Agents | 1 | 2000 | 3 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2000 | 1 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 4 | 0.050 |
Why?
|
| Synaptosomes | 1 | 2020 | 2 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 4 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2000 | 14 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cycloheptanes | 1 | 1980 | 1 | 0.050 |
Why?
|
| Iron Chelating Agents | 1 | 1980 | 1 | 0.050 |
Why?
|
| Tropolone | 1 | 1980 | 1 | 0.050 |
Why?
|
| Monoterpenes | 1 | 1980 | 1 | 0.050 |
Why?
|
| Heart | 1 | 2020 | 13 | 0.050 |
Why?
|
| Arthrogryposis | 1 | 2000 | 9 | 0.050 |
Why?
|
| Biomarkers | 2 | 2017 | 188 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 26 | 0.050 |
Why?
|
| Tay-Sachs Disease | 1 | 1999 | 1 | 0.050 |
Why?
|
| Research | 3 | 1965 | 9 | 0.050 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1999 | 12 | 0.050 |
Why?
|
| Cyanides | 2 | 1998 | 2 | 0.050 |
Why?
|
| Cricetinae | 2 | 1997 | 7 | 0.040 |
Why?
|
| RNA, Transfer, Cys | 1 | 1999 | 1 | 0.040 |
Why?
|
| Artifacts | 1 | 2019 | 5 | 0.040 |
Why?
|
| Epididymis | 2 | 1991 | 5 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 14 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Ruthenium Red | 1 | 1999 | 1 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 164 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 4 | 0.040 |
Why?
|
| Phosphorus Isotopes | 1 | 1999 | 1 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2019 | 30 | 0.040 |
Why?
|
| ras Proteins | 1 | 1999 | 8 | 0.040 |
Why?
|
| Motor Activity | 2 | 2009 | 14 | 0.040 |
Why?
|
| Leukocytes | 1 | 2019 | 22 | 0.040 |
Why?
|
| Microsomes, Liver | 4 | 1991 | 5 | 0.040 |
Why?
|
| PC12 Cells | 3 | 2006 | 3 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 345 | 0.040 |
Why?
|
| International Cooperation | 1 | 2018 | 7 | 0.040 |
Why?
|
| Thermodynamics | 4 | 1991 | 7 | 0.040 |
Why?
|
| Trypsin | 1 | 1998 | 2 | 0.040 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1998 | 1 | 0.040 |
Why?
|
| Dystrophin | 1 | 1998 | 1 | 0.040 |
Why?
|
| DNA, Protozoan | 1 | 1998 | 4 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 14 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 1995 | 9 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2018 | 1 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2018 | 13 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2018 | 17 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 10 | 0.040 |
Why?
|
| Mersalyl | 2 | 1993 | 2 | 0.040 |
Why?
|
| Hydroxybutyrates | 3 | 1990 | 4 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 119 | 0.040 |
Why?
|
| Isocitrates | 2 | 1994 | 2 | 0.040 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 1998 | 2 | 0.040 |
Why?
|
| Complement Factor H | 1 | 2017 | 3 | 0.040 |
Why?
|
| HLA-A Antigens | 1 | 2017 | 9 | 0.040 |
Why?
|
| Age Factors | 2 | 2009 | 56 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 201 | 0.040 |
Why?
|
| Edetic Acid | 2 | 1992 | 2 | 0.040 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2017 | 1 | 0.040 |
Why?
|
| Dizziness | 1 | 2017 | 1 | 0.040 |
Why?
|
| Vertigo | 1 | 2017 | 1 | 0.040 |
Why?
|
| Vigabatrin | 1 | 2017 | 1 | 0.040 |
Why?
|
| Lethargy | 1 | 2017 | 1 | 0.040 |
Why?
|
| Amines | 1 | 2017 | 2 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2017 | 2 | 0.040 |
Why?
|
| Pregabalin | 1 | 2017 | 3 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2017 | 4 | 0.040 |
Why?
|
| Ataxia | 1 | 2017 | 7 | 0.040 |
Why?
|
| Phylogeny | 2 | 2010 | 208 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 1998 | 86 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 12 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 92 | 0.040 |
Why?
|
| Ulnar Nerve | 1 | 2017 | 1 | 0.040 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2017 | 1 | 0.040 |
Why?
|
| Aconitate Hydratase | 2 | 2007 | 3 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1997 | 9 | 0.040 |
Why?
|
| Mesocricetus | 1 | 1997 | 3 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 65 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 2 | 2014 | 3 | 0.040 |
Why?
|
| Peptide Elongation Factors | 1 | 1997 | 3 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 2 | 0.040 |
Why?
|
| Acetates | 3 | 1988 | 5 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2015 | 16 | 0.030 |
Why?
|
| Electrochemistry | 2 | 1993 | 2 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 91 | 0.030 |
Why?
|
| Genitalia, Female | 1 | 1995 | 1 | 0.030 |
Why?
|
| Mucins | 1 | 1995 | 1 | 0.030 |
Why?
|
| Cathepsins | 1 | 1995 | 2 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1995 | 2 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 21 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 34 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 11 | 0.030 |
Why?
|
| Lactic Acid | 2 | 1985 | 4 | 0.030 |
Why?
|
| Hydroxyquinolines | 3 | 1985 | 3 | 0.030 |
Why?
|
| Methacrylates | 3 | 1985 | 4 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 13 | 0.030 |
Why?
|
| Rabbits | 3 | 2001 | 4 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 2008 | 20 | 0.030 |
Why?
|
| Adenosine Monophosphate | 2 | 1992 | 3 | 0.030 |
Why?
|
| Ascites | 2 | 1965 | 2 | 0.030 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 1965 | 2 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 1 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2014 | 1 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 2014 | 1 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2014 | 2 | 0.030 |
Why?
|
| Coenzymes | 2 | 2004 | 2 | 0.030 |
Why?
|
| Eating | 1 | 2014 | 6 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2014 | 4 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 1 | 0.030 |
Why?
|
| Amobarbital | 2 | 2004 | 2 | 0.030 |
Why?
|
| Isomerases | 1 | 1994 | 1 | 0.030 |
Why?
|
| Genes, Helminth | 1 | 1994 | 2 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2013 | 2 | 0.030 |
Why?
|
| Caprylates | 3 | 1997 | 3 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 14 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 15 | 0.030 |
Why?
|
| 3-Hydroxybutyric Acid | 3 | 1990 | 3 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 2 | 0.030 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 1993 | 1 | 0.030 |
Why?
|
| Electron Transport Complex II | 2 | 1964 | 2 | 0.030 |
Why?
|
| Metabolism | 2 | 1964 | 3 | 0.030 |
Why?
|
| Phosphate-Binding Proteins | 1 | 1993 | 2 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1985 | 2 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 2013 | 1 | 0.030 |
Why?
|
| Wrist | 1 | 2013 | 1 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Myelin Proteins | 1 | 2013 | 2 | 0.030 |
Why?
|
| Connexins | 1 | 2013 | 6 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2013 | 4 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 6 | 0.030 |
Why?
|
| Gene Components | 1 | 2013 | 4 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2013 | 5 | 0.030 |
Why?
|
| Comorbidity | 1 | 2013 | 18 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 13 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 14 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 14 | 0.030 |
Why?
|
| Spectrophotometry | 3 | 2001 | 4 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 40 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 5 | 0.030 |
Why?
|
| Biotin | 1 | 1992 | 1 | 0.030 |
Why?
|
| Colorimetry | 1 | 1992 | 1 | 0.030 |
Why?
|
| Heating | 1 | 1992 | 1 | 0.030 |
Why?
|
| Nucleic Acid Probes | 1 | 1992 | 1 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1992 | 2 | 0.030 |
Why?
|
| Fluorescein | 1 | 1992 | 2 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 15 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2013 | 62 | 0.030 |
Why?
|
| Stroke | 1 | 2012 | 17 | 0.030 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2012 | 1 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2012 | 1 | 0.030 |
Why?
|
| Luciferases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2012 | 5 | 0.030 |
Why?
|
| Acclimatization | 1 | 2012 | 5 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 3 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2012 | 5 | 0.030 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 3 | 0.030 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2012 | 2 | 0.030 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2012 | 3 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2012 | 5 | 0.030 |
Why?
|
| Lipolysis | 1 | 2012 | 5 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 3 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 54 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1992 | 43 | 0.030 |
Why?
|
| Aminooxyacetic Acid | 1 | 1992 | 1 | 0.030 |
Why?
|
| Ammonia | 1 | 1992 | 5 | 0.030 |
Why?
|
| Cell Separation | 1 | 2012 | 30 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2012 | 48 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 11 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2012 | 1 | 0.030 |
Why?
|
| Glucosylceramides | 1 | 2012 | 1 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2012 | 1 | 0.030 |
Why?
|
| Streptozocin | 1 | 2012 | 1 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2012 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 4 | 0.030 |
Why?
|
| Auranofin | 1 | 2012 | 1 | 0.030 |
Why?
|
| Dinitrochlorobenzene | 1 | 2012 | 1 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2012 | 1 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 2012 | 4 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2012 | 1 | 0.030 |
Why?
|
| Catalase | 1 | 2012 | 6 | 0.030 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 4 | 0.030 |
Why?
|
| Astrocytes | 1 | 2012 | 10 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 7 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 56 | 0.030 |
Why?
|
| Ferritins | 1 | 1992 | 2 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 51 | 0.030 |
Why?
|
| Genome | 1 | 1992 | 77 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2012 | 1 | 0.030 |
Why?
|
| Facial Expression | 1 | 2012 | 2 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2012 | 25 | 0.030 |
Why?
|
| Autophagy | 1 | 2012 | 20 | 0.030 |
Why?
|
| Reflex, Startle | 1 | 2012 | 2 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 9 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 10 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2012 | 46 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2012 | 120 | 0.030 |
Why?
|
| Magnesium | 4 | 1987 | 6 | 0.020 |
Why?
|
| Orotic Acid | 1 | 1991 | 2 | 0.020 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 1991 | 1 | 0.020 |
Why?
|
| Malonates | 1 | 1991 | 1 | 0.020 |
Why?
|
| Palmitoylcarnitine | 1 | 1991 | 1 | 0.020 |
Why?
|
| Elasticity | 1 | 1991 | 2 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 146 | 0.020 |
Why?
|
| Ethidium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2010 | 1 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 1991 | 8 | 0.020 |
Why?
|
| Gene Library | 3 | 1997 | 20 | 0.020 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1990 | 1 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 8 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 10 | 0.020 |
Why?
|
| Acrylates | 1 | 2010 | 1 | 0.020 |
Why?
|
| Calcimycin | 1 | 2010 | 2 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 39 | 0.020 |
Why?
|
| Ouabain | 1 | 1990 | 1 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2009 | 1 | 0.020 |
Why?
|
| Cell Nucleus Shape | 1 | 2009 | 1 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 8 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 7 | 0.020 |
Why?
|
| Cell Shape | 1 | 2009 | 4 | 0.020 |
Why?
|
| Escherichia coli | 3 | 1995 | 57 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 1 | 0.020 |
Why?
|
| KATP Channels | 1 | 2009 | 2 | 0.020 |
Why?
|
| Glucose | 2 | 2007 | 36 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2009 | 18 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 11 | 0.020 |
Why?
|
| Olfaction Disorders | 1 | 2009 | 1 | 0.020 |
Why?
|
| Compulsive Behavior | 1 | 2009 | 1 | 0.020 |
Why?
|
| Phencyclidine | 1 | 2009 | 1 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2009 | 1 | 0.020 |
Why?
|
| Motor Skills Disorders | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sensory Gating | 1 | 2009 | 3 | 0.020 |
Why?
|
| Haloperidol | 1 | 2009 | 2 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 2 | 0.020 |
Why?
|
| Drinking | 1 | 2009 | 2 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 3 | 0.020 |
Why?
|
| Uterus | 1 | 2009 | 4 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 10 | 0.020 |
Why?
|
| Fatty Acids, Volatile | 1 | 1988 | 1 | 0.020 |
Why?
|
| Liver Failure | 1 | 2008 | 1 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 4 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Hearing Aids | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2008 | 3 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1995 | 7 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2008 | 1 | 0.020 |
Why?
|
| Muscle, Striated | 1 | 2008 | 1 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2008 | 3 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2008 | 6 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 20 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 39 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 31 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 37 | 0.020 |
Why?
|
| Sex Factors | 2 | 1998 | 35 | 0.020 |
Why?
|
| Water | 2 | 2006 | 14 | 0.020 |
Why?
|
| Antibodies, Helminth | 2 | 2001 | 2 | 0.020 |
Why?
|
| Parahippocampal Gyrus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2007 | 3 | 0.020 |
Why?
|
| Citrulline | 3 | 1983 | 4 | 0.020 |
Why?
|
| Oleic Acids | 2 | 1989 | 2 | 0.020 |
Why?
|
| Oleic Acid | 2 | 1989 | 4 | 0.020 |
Why?
|
| Pyrrolidinones | 1 | 1987 | 1 | 0.020 |
Why?
|
| Anthraquinones | 2 | 1985 | 3 | 0.020 |
Why?
|
| Epidermis | 1 | 2006 | 6 | 0.020 |
Why?
|
| Thiazoles | 2 | 1985 | 5 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 4 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2001 | 8 | 0.020 |
Why?
|
| Swimming | 1 | 2006 | 1 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2006 | 17 | 0.020 |
Why?
|
| Video Recording | 1 | 2006 | 3 | 0.020 |
Why?
|
| Alkenes | 2 | 1985 | 2 | 0.020 |
Why?
|
| Strobilurins | 2 | 1985 | 3 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1985 | 5 | 0.020 |
Why?
|
| Homocysteine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Trigeminal Nuclei | 1 | 2006 | 1 | 0.020 |
Why?
|
| Thalamus | 1 | 2006 | 2 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2006 | 5 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1997 | 21 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2006 | 12 | 0.020 |
Why?
|
| Dinitrophenols | 2 | 1989 | 2 | 0.020 |
Why?
|
| Dithionite | 1 | 1985 | 1 | 0.020 |
Why?
|
| Flavins | 1 | 1985 | 1 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2005 | 9 | 0.020 |
Why?
|
| Vanadates | 1 | 1985 | 1 | 0.020 |
Why?
|
| Vanadium | 1 | 1985 | 1 | 0.020 |
Why?
|
| Glipizide | 1 | 2005 | 1 | 0.020 |
Why?
|
| Sulfonylurea Compounds | 1 | 2005 | 1 | 0.020 |
Why?
|
| Hydrogen | 2 | 1983 | 2 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1985 | 1 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1985 | 3 | 0.020 |
Why?
|
| Diptera | 1 | 1985 | 4 | 0.020 |
Why?
|
| Methods | 4 | 1978 | 4 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1985 | 13 | 0.020 |
Why?
|
| Tropanes | 1 | 2005 | 1 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 1 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 3 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1985 | 2 | 0.020 |
Why?
|
| Glycerol | 1 | 1985 | 3 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2004 | 3 | 0.020 |
Why?
|
| Carcinoma | 1 | 1965 | 10 | 0.020 |
Why?
|
| Codon | 1 | 2004 | 12 | 0.020 |
Why?
|
| Columbidae | 1 | 1984 | 1 | 0.020 |
Why?
|
| Free Radicals | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cell-Free System | 2 | 1983 | 4 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2004 | 2 | 0.020 |
Why?
|
| Fathers | 1 | 2004 | 3 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2005 | 82 | 0.020 |
Why?
|
| Mothers | 1 | 2004 | 8 | 0.020 |
Why?
|
| Citrates | 1 | 1964 | 1 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1964 | 2 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 1964 | 6 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1981 | 3 | 0.020 |
Why?
|
| Palmitic Acids | 2 | 1989 | 3 | 0.010 |
Why?
|
| Potentiometry | 1 | 1983 | 1 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 2 | 0.010 |
Why?
|
| Adenine | 1 | 2003 | 7 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1963 | 1 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 11 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 16 | 0.010 |
Why?
|
| Spleen | 1 | 1963 | 10 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1983 | 1 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 17 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1983 | 8 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1963 | 10 | 0.010 |
Why?
|
| Binding Sites | 1 | 1983 | 73 | 0.010 |
Why?
|
| Oxalates | 1 | 1963 | 1 | 0.010 |
Why?
|
| Oxaloacetic Acid | 1 | 1963 | 1 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2003 | 32 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2003 | 9 | 0.010 |
Why?
|
| Lung | 1 | 1963 | 35 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2002 | 2 | 0.010 |
Why?
|
| Protons | 3 | 1989 | 3 | 0.010 |
Why?
|
| Cations | 1 | 1982 | 1 | 0.010 |
Why?
|
| Strontium | 1 | 1982 | 1 | 0.010 |
Why?
|
| 14-3-3 Proteins | 1 | 2001 | 2 | 0.010 |
Why?
|
| Calsequestrin | 1 | 2001 | 1 | 0.010 |
Why?
|
| Titrimetry | 1 | 2001 | 1 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 1 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2001 | 2 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1961 | 2 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2001 | 3 | 0.010 |
Why?
|
| Tetracycline | 1 | 2001 | 2 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 2 | 0.010 |
Why?
|
| Drosophila | 1 | 1980 | 15 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1981 | 36 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 2000 | 1 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 2000 | 1 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 1 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2000 | 1 | 0.010 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2000 | 1 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 5 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2000 | 4 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 3 | 0.010 |
Why?
|
| Delirium | 1 | 2000 | 4 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 30 | 0.010 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2000 | 1 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 10 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 92 | 0.010 |
Why?
|
| Trichloroethylene | 1 | 1979 | 1 | 0.010 |
Why?
|
| Vinyl Chloride | 1 | 1979 | 1 | 0.010 |
Why?
|
| Vinyl Compounds | 1 | 1979 | 1 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 196 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 1991 | 4 | 0.010 |
Why?
|
| Densitometry | 1 | 1998 | 1 | 0.010 |
Why?
|
| Liberia | 1 | 1998 | 1 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1998 | 1 | 0.010 |
Why?
|
| Mice, Inbred mdx | 1 | 1998 | 1 | 0.010 |
Why?
|
| RNA, Helminth | 1 | 1998 | 3 | 0.010 |
Why?
|
| Electromyography | 1 | 1998 | 2 | 0.010 |
Why?
|
| Azides | 1 | 1997 | 1 | 0.010 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Bombyx | 1 | 1997 | 2 | 0.010 |
Why?
|
| Osmotic Pressure | 2 | 1994 | 8 | 0.010 |
Why?
|
| Coenzyme A | 1 | 1976 | 1 | 0.010 |
Why?
|
| Ketoglutaric Acids | 2 | 1988 | 2 | 0.010 |
Why?
|
| Epithelium | 1 | 1995 | 14 | 0.010 |
Why?
|
| Algorithms | 1 | 1997 | 165 | 0.010 |
Why?
|
| Cathepsin L | 1 | 1995 | 2 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1995 | 97 | 0.010 |
Why?
|
| Porins | 1 | 1994 | 1 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1994 | 3 | 0.010 |
Why?
|
| Digestive System | 1 | 1994 | 1 | 0.010 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1994 | 1 | 0.010 |
Why?
|
| Testis | 1 | 1994 | 5 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 47 | 0.010 |
Why?
|
| Kidney | 1 | 1994 | 38 | 0.010 |
Why?
|
| Heterocyclic Compounds | 1 | 1973 | 4 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 1973 | 9 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1972 | 8 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 6 | 0.010 |
Why?
|
| Organ Size | 1 | 1991 | 9 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1971 | 1 | 0.010 |
Why?
|
| Body Weight | 1 | 1991 | 13 | 0.010 |
Why?
|
| Membranes | 1 | 1971 | 1 | 0.010 |
Why?
|
| Insulins | 1 | 1950 | 5 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1970 | 1 | 0.010 |
Why?
|
| Centrifugation | 1 | 1970 | 2 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1970 | 2 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1970 | 6 | 0.010 |
Why?
|
| 2,4-Dinitrophenol | 1 | 1989 | 1 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1989 | 1 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1985 | 3 | 0.010 |
Why?
|
| Biological Transport | 1 | 1989 | 30 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1988 | 1 | 0.010 |
Why?
|
| Light | 1 | 1969 | 14 | 0.010 |
Why?
|
| Butyrates | 1 | 1988 | 3 | 0.010 |
Why?
|
| Pressure | 1 | 1987 | 3 | 0.000 |
Why?
|
| Culture Media | 1 | 1967 | 8 | 0.000 |
Why?
|
| Hypoxia | 1 | 1987 | 6 | 0.000 |
Why?
|
| Glutathione Transferase | 1 | 1985 | 5 | 0.000 |
Why?
|
| Epoxide Hydrolases | 1 | 1985 | 2 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1985 | 15 | 0.000 |
Why?
|
| Glucosephosphates | 1 | 1983 | 1 | 0.000 |
Why?
|
| Glucose-6-Phosphate | 1 | 1983 | 1 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 3 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1983 | 1 | 0.000 |
Why?
|
| Tritium | 1 | 1983 | 2 | 0.000 |
Why?
|
| Keto Acids | 1 | 1982 | 1 | 0.000 |
Why?
|
| Energy Transfer | 1 | 1982 | 3 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1981 | 1 | 0.000 |
Why?
|
| Ornithine | 1 | 1981 | 1 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1981 | 2 | 0.000 |
Why?
|
| Alkylation | 1 | 1979 | 1 | 0.000 |
Why?
|
| Cytidine | 1 | 1979 | 2 | 0.000 |
Why?
|
| Adenosine | 1 | 1979 | 8 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1979 | 18 | 0.000 |
Why?
|
| Oxathiins | 1 | 1973 | 1 | 0.000 |
Why?
|
| Digitalis Glycosides | 1 | 1971 | 1 | 0.000 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1971 | 1 | 0.000 |
Why?
|
| Hypotonic Solutions | 1 | 1971 | 1 | 0.000 |
Why?
|
| Nucleotidases | 1 | 1971 | 1 | 0.000 |
Why?
|
| Ultrasonics | 1 | 1971 | 1 | 0.000 |
Why?
|
| Histological Techniques | 1 | 1971 | 2 | 0.000 |
Why?
|
| Freezing | 1 | 1971 | 2 | 0.000 |
Why?
|
| Monoamine Oxidase | 1 | 1971 | 2 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1971 | 2 | 0.000 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1971 | 5 | 0.000 |
Why?
|
| Nitrogen | 1 | 1971 | 10 | 0.000 |
Why?
|
